RankingsPricing
  1. US-listed companies
  2. BOSTON SCIENTIFIC CORP
  3. Financials
  4. EBITDA

BOSTON SCIENTIFIC CORPBSX

Market cap
$150B
P/E ratio
SummaryFinancials
Period EndEBITDA (Million USD)YoY (%)
Dec 31, 20243,872+9.41%
Dec 31, 20233,539+27.07%
Dec 31, 20222,785+21.51%
Dec 31, 20212,292+119.75%
Dec 31, 20201,043-58.76%
Dec 31, 20192,529+5.38%
Dec 31, 20182,400+12.73%
Dec 31, 20172,129+68.70%
Dec 31, 20161,262+185.52%
Dec 31, 2015442+4.25%
Dec 31, 2014424-47.59%
Dec 31, 2013809-125.40%
Dec 31, 2012-3,185-296.48%
Dec 31, 20111,621

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)